Differential effects of the 5HT(1B/1D) receptor agonist naratriptan on trigeminal versus spinal nociceptive responses

Cephalalgia

Volumn 18, Issue 10, 1998, Pages 659-663

  Cumberbatch, M J ^a   Hill, R G ^a   Hargreaves, R J ^a  

^a Merck Sharp & Dohme Limited   (United Kingdom)

Author keywords

5HT(1B 1D); Electrophysiology; Naratriptan; Spinal dorsal horn; Trigeminal dorsal horn

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; NARATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; INDOLE DERIVATIVE; PIPERIDINE DERIVATIVE; SEROTONIN AGONIST; TRYPTAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MECHANICAL STIMULATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; RAT; SPINAL CORD DORSAL HORN; TRIGEMINAL NERVE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; DURA MATER; ELECTROSTIMULATION; MECHANICAL STRESS; SPINAL CORD; SPRAGUE DAWLEY RAT;

ANIMALS; DRUG EVALUATION, PRECLINICAL; DURA MATER; ELECTRIC STIMULATION; INDOLES; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; SPINAL CORD; STRESS, MECHANICAL; TRIGEMINAL NERVE; TRYPTAMINES;

EID: 0032241022     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1998.1810659.x     Document Type: Article

References (34)

1. Besson JM, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev 1987;67:67-186
2. Cooper BY, Sessle BJ. Physiology of nociception in the trigeminal system. In: Olsen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press, 1993:87-92
3. Strassman AM, Mason P, Moskowitz MA, Maciewicz R. Response of trigeminal neurons to electrical stimulation of the dura. Brain Res 1986;379:242-50
4. Davis KD, Dostrovsky JO. Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain 1986;25:395-401
5. Davis KD, Dostrovsky JO. Responses of feline trigeminal spinal tract nucleus neurons to stimulation of the middle meningeal artery and sagittal sinus. J Neurophysiol 1988; 59:648-66
6. Cumberbatch MJ, Hill RG, Hargreaves RJ. Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol 1997;328:37-40
7. Goadsby PJ, Hoskin KL. Inhibition of trigeminal neurones by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain 1996;67:355-9
8. Goadsby PJ, Knight Y. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Br J Pharmacol 1997;122:918-22
9. Bruinvels AT, Landwehrmeyer B, Moskowitz MA, Hoyer D. Evidence for the presence of 5-HT1B receptor messenger mRNA in neurones of the rat trigeminal ganglia. Eur J Pharmacol 1992;227:357-9
10. Bruinvels AT, Landwehrmeyer B, Probst A, Palacios JM, Hoyer D. A comparative autoradiographic study of 5HT-1D binding sites in human and guinea-pig brain using different radioligands. Mol Brain Res 1994:21
11. Mills A, Martin GR. Autoradiographic mapping of [3H]sumatriptan binding in cat brain stem and spinal cord. Eur J Pharmacol 1995;280:175-8
12. Bouchelet I, Cohen ZVI, Case B, Séguéla P, Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytriptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol 1996;50:219-23
13. Longmore J, Shaw D, Smith D, Hopkins R, McAllister G, Pickard JD, et al. Differential distribution of 5HT1D- and SHT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997;17:833-42
14. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992;13:307-11
15. Williamson DJ, Shepheard SL, Hill RG, Hargreaves RJ. The novel anti-migraine agent rizatriptan inhibits neurogenic vasodilation and extravasation. Eur J Pharmacol 1997;328:61-4
16. Matsumoto I, Combs MR, Jones DJ. Characterization of 5-hydroxytriptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytriptamine release. J Pharmacol Exp Ther 1992;260: 614-26
17. Arvieu L, Mauborgne A, Bourgoin S, Oliver C, Feltz P, Hamon M, et al. Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport 1996;7:1973-6
18. Ali Z, Wu G, Kozlov A, Barasi S. The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Brain Res 1994;661:83-90
19. El-Yassir N, Fleetwood-Walker SM, Mitchell R. Heterogeneous effects of serotonin in the dorsal horn of the rat: the involvement of 5-HT1 receptor subtypes. Brain Res 1988;456:147-58
20. Murphy AZ, Murphy RM, Zemlan FP. Role of spinal serotonin1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes. Psychopharmacology 1992; 108:123-30
21. Connor HE, Feniuk W, Beattie DT, North PC, Oxford AW, Saynor DA, et al. Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia 1997;17:145-52
22. Cumberbatch MJ, Hill RG, Hargreaves RJ. Differential effects of naratriptan on spinal vs trigeminal nociceptive responses. Cephalalgia 1997;17:381
23. Dao TT, Lund JP, Remillard G, Lavigne GJ. Is myofascial pain of the temporal muscles relieved by oral sumatriptan? A cross-over pilot study. Pain 1995;62:241-4
24. Roberts-Thomson I, Argyrides J, Pannall P, Frewin D. Sumatriptan and episodic pain syndromes other than migraine. Pain 1996;67:226-7
25. Dalessio DJ, Silberstein SD. Diagnosis and classification of headache. In: Dalessio DJ, Silberstein SD, editors. Wolff's headache, 6th ed. Oxford: Oxford University Press, 1993; 3-18
26. Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, et al. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br J Pharmacol 1992;105:732-8
27. Alhaider AA, Wilcox GL. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 1998;265:378-85
28. 1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Eur J Pharmacol 1998;362:43-46
29. Gjerstad J, Tjolsen A, Hole K. A dual effect of 5-HT1B receptor stimulation on nociceptive dorsal horn neurones in rats. Eur J Pharmacol 1997;335:127-32
30. Manuel NA, Wallis DI, Crick H. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Br J Pharmacol 1995;116:2647-54
31. Skingle M, Birch PJ, Leighton GE, Humphrey PP. Lack of antinociceptive activity of sumatriptan in rodents. Cephalalgia 1990;10:207-12
32. Thomsen LL, Brennum J, Iversen HK, Olesen J. Effect of a nitric oxide donor (glyceryl trinitrate) on nociceptive thresholds in man. Cephalalgia 1996;16:169-74
33. 1B/1D agonist. J Physiol 1997;504P:103P-4P
34. Williamson DJ, Cumberbatch MJ, Shepheard SL, Hargreaves RJ. Sensitization of caudal trigeminal neurones by dural artery dilatation. Neurology 1998;50:A227